Mary M. Chen

953 total citations
9 papers, 656 citations indexed

About

Mary M. Chen is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, Mary M. Chen has authored 9 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Mary M. Chen's work include Cancer therapeutics and mechanisms (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Nuclear Receptors and Signaling (3 papers). Mary M. Chen is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers) and Nuclear Receptors and Signaling (3 papers). Mary M. Chen collaborates with scholars based in United States. Mary M. Chen's co-authors include Thomas Quertermous, Euan A. Ashley, Philip S. Tsao, Robert C. Robbins, Hyung J. Chun, Ahmad Y. Sheikh, Brett E. Fenster, David Deng, Frances L. Johnson and Raymond Tabibiazar and has published in prestigious journals such as Circulation, Blood and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Mary M. Chen

9 papers receiving 645 citations

Peers

Countries citing papers authored by Mary M. Chen

Since Specialization

Citations

This map shows the geographic impact of Mary M. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary M. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary M. Chen more than expected).

Fields of papers citing papers by Mary M. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary M. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary M. Chen. The network helps show where Mary M. Chen may publish in the future.

Co-authorship network of co-authors of Mary M. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mary M. Chen. A scholar is included among the top collaborators of Mary M. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary M. Chen. Mary M. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia 2025 ·Leukemia ·Sameem Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, (unknown), (unknown), Mary M. Chen, (unknown), (unknown), (unknown), Madhuri Vusirikala, (unknown), Ehab Atallah	4
2	Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML 2022 ·Blood ·Gary J. Schiller, Laura Finn, (unknown), Johnnie J. Orozco, (unknown), Mary M. Chen, Gail J. Roboz	2
3	Lintuzumab-Ac225 with Combination with Intensive Chemotherapy Yields High Response Rate and MRD Negativity in R/R AML with Adverse Features 2022 ·Blood ·Sameem Abedin, Guru Subramanian Guru Murthy, Anikó Szabó, Mehdi Hamadani, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, (unknown), (unknown), Mary M. Chen, Alexandra M. Harrington, Ehab Atallah	7
4	Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML 2021 ·Blood ·Gary J. Schiller, Laura Finn, Gail J. Roboz, Johnnie J. Orozco, Tiffany Lin, Mary M. Chen, (unknown)	2
5	A Multifaceted Mentoring Program for Junior Faculty in Academic Pediatrics 2016 ·Teaching and Learning in Medicine ·Mary M. Chen, Christy Sandborg, Louanne Hudgins, (unknown), Laura K. Bachrach	67
6	A feasibility study to evaluate breast cancer patients’ knowledge of their diagnosis and treatment 2012 ·Patient Education and Counseling ·Stephanie M. Smith, Raymond R. Balise, Catherine Norton, Mary M. Chen, (unknown), Alice E. Guardino	7
7	Endogenous regulation of cardiovascular function by apelin-APJ 2009 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), Michael Ho, Giovanni Fajardo, Masataka Kawana, Ramendra K. Kundu, Ahmad Y. Sheikh, (unknown), Nicholas J. Leeper, (unknown), Mary M. Chen, (unknown), Hyung J. Chun, Daniel Bernstein, Euan A. Ashley, Thomas Quertermous	159
8	In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure 2007 ·American Journal of Physiology-Heart and Circulatory Physiology ·Ahmad Y. Sheikh, Hyung J. Chun, Alexander J. Glassford, (unknown), Ingo Kutschka, Diego Ardigò, Stephen L. Hendry, Roger A. Wagner, Mary M. Chen, Ziad A. Ali, Patrick Yue, Diem Thi Ngoc Huynh, Andrew J. Connolly, Marc Pelletier, Philip S. Tsao, Robert C. Robbins, Thomas Quertermous	118
9	Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction 2003 ·Circulation ·Mary M. Chen, Euan A. Ashley, David Deng, Anya Tsalenko, Alicia Deng, Raymond Tabibiazar, Amir Ben‐Dor, Brett E. Fenster, Eugene Yang, Jennifer Y. King, Michael B. Fowler, Robert C. Robbins, Frances L. Johnson, Laurakay Bruhn, Theresa McDonagh, Henry Dargie, Zohar Yakhini, Philip S. Tsao, Thomas Quertermous	290

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact